| Literature DB >> 8916486 |
C M Goods1, K F al-Shaibi, M W Liu, J S Yadav, A Mathur, S P Jain, L S Dean, S S Iyer, J M Parks, G S Roubin.
Abstract
This prospective nonrandomized study was performed comparing aspirin alone (n = 46) versus aspirin and ticlopidine (p = 338) following native coronary artery stenting. There were significantly more stent thrombosis events in the aspirin-only group than in the aspirin and ticlopidine group (6.5% vs 0.9%, p = 0.02) and significantly more Q-wave myocardial infarctions and cardiac-related deaths in the aspirin-only group than in the aspirin and ticlopidine group (6.5% vs 0%, p = 0.002 and 4.4% vs 0.3% p = 0.02, respectively).Entities:
Mesh：
Substances：
Year: 1996 PMID： 8916486 DOI： 10.1016/s0002-9149(96)00532-2
Source DB: PubMed Journal: Am J Cardiol ISSN： 0002-9149 Impact factor: 2.778